How to Cite
Abstract
Leprosy, an infectious, granulomatous neurocutaneous disease, has plagued humans since pre-biblical times. Although the etiological agent of leprosy was described more than 150 years ago, the situation remains worrying, given that 172,717 new cases were reported worldwide in 2024. This report showed that Brazil, India, and Indonesia account for 80% of cases globally. In this context, it is essential to put leprosy on the radar of public policies for financing applied research in the production, improvement, and dissemination of scientific knowledge. To this end, collective action by scholars and government officials will be necessary to address the challenges that leprosy poses.
References
1. Mehta H, Jain S, Narang T, Chhabra S, Dogra S. Leprosy reactions: new knowledge on pathophysiology, diagnosis, treatment and prevention. Indian J Dermatol Venereol Leprol. 2025;91(4):470-81. doi: https://doi.org/10.25259/IJDVL_915_2024.
2. Santacroce L, Del Prete R, Charitos IA, Bottalico L. Mycobacterium leprae: a historical study on the origins of leprosy and its social stigma. Le Infezioni in Medicina, 2021;4:623-32. doi: https://doi.org/10.53854/liim-2904-18.
3. World Health Organization. Control of Neglected Tropical Diseases. Switzerland: WHO; 2025. [cited 2025 Dec. 15]. Available from:https://www.who.int/teams/control-of-neglected-tropical-diseases/leprosy/treatment.
4. World Health Organization. Global leprosy (Hansen disease) update, 2024: beyond zero cases – what elimination of leprosy really means. Wkly. Epidemiol. Rec. 12 12 September 2025;100(37):365 – 84. [cited 2025 Dec. 12]. Available from: https://iris.who.int/server/api/core/bitstreams/e49b759d-984c-497d-bd51-3cd366f6eed9/content.
5. Jesus JB, Sena CBC, Macchi BM, do Nascimento JLM. Cyclosporin A as an alternative neuroimmune strategy to control neurites and recover neuronal tissues in leprosy. Neuroimmunomodulation. 2022;29(1):15-20. doi: https://doi.org/10.1159/000517993.
6. Calderone A, Aloisi MC, Casella C, Fiannacca S, Cosenza B, Quartarone Angelo, et al. The neurological impact of leprosy: manifestations and treatment approaches. Neurol. Int. 2024;16(6):1492–508. doi: https://doi.org/10.3390/neurolint16060111.
7. Ebenezer GJ, Scollard DM. Treatment and evaluation advances in leprosy neuropathy. Neurotherapeutics. 2021;18(4):2337–50. doi: https://doi.org/10.1007/s13311-021-01153-z.
8. Darmi M, Johari A, Sahrial S, Guspianto G. Health education method on leprosy prevention: integrative review. Arch Razi Inst. 2024;79(1):1-12. doi: https://doi.org/10.32592/ARI.2024.79.1.1.
9. Quaglio LH, Brito de Souza VN, Prado RBR, Belone AFF, Souza-Santana FC. Intervenção educativa por meio de metodologia participativa sobre hanseníase com professores de escola estadual no município de Bauru, São Paulo, Brasil. Hansen Int. 2025;50:e.41815. doi: https://doi.org/10.47878/hi.2025.v.50.41815.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dejair Caitano do Nascimento
Downloads
